SANDS ARTHUR T
Insider CIK 1134106 · LXRX President & CEO, Director · NRIX President, CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2026-02-10 | 2026-02-10 | 562,500 | — | $0 | 562,500 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2025-02-11 | 2025-02-13 | 450,000 | — | $0 | 450,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 800,000 | — | $0 | 800,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2023-02-14 | 2023-02-15 | 448,000 | — | $0 | 448,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2022-08-09 | 2022-08-10 | 400,000 | — | $0 | 400,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2022-01-20 | 2022-01-21 | 300,000 | — | $0 | 300,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2021-02-11 | 2021-02-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| NRIX Nurix Therapeutics, Inc. | A Award deriv | 2020-10-21 | 2020-10-23 | 804,170 | — | $0 | 804,170 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 37,000 | — | $0 | 74,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 36,250 | — | $0 | 36,250 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 35,000 | — | $0 | 105,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2014-02-28 | 2014-03-03 | 29,791 | $1.92 | $57.2K | 1,021,329 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 35,000 | — | $0 | 1,051,120 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 37,000 | — | $0 | 1,016,120 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 36,250 | — | $0 | 979,120 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 36,250 | — | $0 | 72,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 37,000 | — | $0 | 111,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 36,250 | — | $0 | 925,904 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-02-28 | 2013-03-01 | 20,034 | $1.98 | $39.7K | 942,870 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 37,000 | — | $0 | 962,904 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 140,000 | — | $0 | 140,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 560,000 | — | $0 | 560,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-01-31 | 2013-02-04 | 73,700 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-01-31 | 2013-02-04 | 21,434 | $2.11 | $45.2K | 889,654 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-01-31 | 2013-02-04 | 73,700 | — | $0 | 911,088 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2012-02-28 | 2012-03-01 | 36,250 | — | $0 | 108,750 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2012-02-28 | 2012-03-01 | 36,250 | — | $0 | 846,976 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2012-02-28 | 2012-03-01 | 9,588 | $1.78 | $17.1K | 837,388 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 592,000 | — | $0 | 592,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 148,000 | — | $0 | 148,000 | SEC↗ |